The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Kringle Domains of Human Angiostatin
Open accessAbstract
Recently we have identified angiostatin, an endogenous angiogenesis inhibitor of 38 kDa which specifically blocks the growth of endothelial cells (O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C. , Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. (1994) Cell 79, 315-328; Folkman, J. (1995) Nat. Med. 1, 27-31). Angiostatin was shown to represent an internal fragment of plasminogen containing the first four kringle structures. We now report on the inhibitory effects of individual or combined kringle structures of angiostatin on capillary endothelial cell proliferation. Recombinant kringle 1 and kringle 3 exhibit potent inhibitory activity with half-maximal concentrations (ED50) of 320 nM and 460 nM, respectively. Also, recombinant kringle 2 displays a significant inhibition, although decreased compared with both kringle 1 and kringle 3. In contrast, kringle 4 is an ineffective inhibitor of basic fibroblast growth factor-stimulated endothelial cell proliferation. Among the tandem kringle arrays, the recombinant kringle 2-3 fragment exerts inhibitory activity similar to kringle 2 alone. However, relative to kringle 2-3, a marked enhancement in inhibition is observed when individual kringle 2 and kringle 3 are added together to endothelial cells. This implies that it is necessary to open the cystine bridge between kringle 2 and kringle 3 to obtain the maximal inhibitory effect of kringle 2-3. An increased (<2-fold) inhibitory activity is observed for the kringle 1-3 fragment (ED50 = 70 nM) compared with kringle 1-4 (ED50 = 135 nM). These data indicate that the anti-proliferative activity of angiostatin on endothelial cells is shared by kringle 1, kringle 2, and kringle 3, but probably not by kringle 4 and that more potent inhibition results when kringle 4 is removed from angiostatin. Thus, in view of the variable lysine affinity of the homologous domains, it would appear that lysine binding capability does not correlate with the relative inhibitory effects of the kringle-containing constructs. However, as we also demonstrate, appropriate folding of kringle structures is essential for angiostatin to maintain its full anti-endothelial activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Self-citationAngiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Self-citationO'Reilly, M. (1994) · Cell · doi:10.1016/0092-8674(94)90200-3 · Cited by 3,345
Self-citationFolkman, J., & Shing, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49853-0 · Cited by 2,654
Self-citationTransplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Self-citationFerrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
Clinical Applications of Research on Angiogenesis
Folkman, J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332608 · Cited by 2,264
Self-citationIntegrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Interleukin-8 as a macrophage-derived mediator of angiogenesis
Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., & Strieter, R. M. (1992) · Science · doi:10.1126/science.1281554 · Cited by 2,135
cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
McLean, J. W., Tomlinson, J. E., Kuang, W.-J., Eaton, D. L., Chen, E. Y., Fless, G. M., Scanu, A. M., & Lawn, R. M. (1987) · Nature · doi:10.1038/330132a0 · Cited by 1,886
Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins
FERRARA, N., HOUCK, K., JAKEMAN, L., & LEUNG, D. W. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-18 · Cited by 1,655
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
Definition of Two Angiogenic Pathways by Distinct α v Integrins
Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., & Cheresh, D. A. (1995) · Science · doi:10.1126/science.270.5241.1500 · Cited by 1,321
Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli
Pennica, D., Holmes, W. E., Kohr, W. J., Harkins, R. N., Vehar, G. A., Ward, C. A., Bennett, W. F., Yelverton, E., Seeburg, P. H., Heyneker, H. L., et al. (1983) · Nature · doi:10.1038/301214a0 · Cited by 1,243
Angiostatin induces and sustains dormancy of human primary tumors in mice
O'Reilly, M. S., Holmgren, L., Chen, C., & Folkman, J. (1996) · Nature Medicine · doi:10.1038/nm0696-689 · Cited by 1,184
Self-citationGood, D. J., Polverini, P. J., Rastinejad, F., Le Beau, M. M., Lemons, R. S., Frazier, W. A., & Bouck, N. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6624 · Cited by 1,054
Long-term culture of capillary endothelial cells.
Folkman, J., Haudenschild, C. C., & Zetter, B. R. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.10.5217 · Cited by 772
Self-citationInhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides
Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F., & Sharpe, R. J. (1990) · Science · doi:10.1126/science.1688470 · Cited by 697
Tolsma, S., Volpert, O., Good, D., Frazier, W., Polverini, P., & Bouck, N. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.2.497 · Cited by 573
Gospodarowicz, D., Abraham, J. A., & Schilling, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7311 · Cited by 559
Senger, D. R., Connolly, D. T., Water, L. V. D., Feder, J., & Dvorak, H. F. (1990) · PubMed · Cited by 500
Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules
Patthy, L. (1985) · Cell · doi:10.1016/s0092-8674(85)80046-5 · Cited by 491
Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. F., & Folkman, J. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.5.356 · Cited by 464
Self-citationThe 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis
Clapp, C., MARTIAL, J. A., Guzman, R. C., Rentier-Delure, F., & Weiner, R. I. (1993) · Endocrinology · doi:10.1210/en.133.3.1292 · Cited by 340
GÜNZLER, W. A., STEFFENS, G. J., ÖTTING, F., KIM, S.-M. A., FRANKUS, E., & FLOHÉ, L. (1982) · Hoppe-Seyler´s Zeitschrift für physiologische Chemie · doi:10.1515/bchm2.1982.363.2.1155 · Cited by 312
Van Meir, E. G., Polverini, P. J., Chazin, V. R., Su Huang, H.-J., de Tribolet, N., & Cavenee, W. K. (1994) · Nature Genetics · doi:10.1038/ng1094-171 · Cited by 307
Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein
Jackson, D., Volpert, O., Bouck, N., & Linzer, D. (1994) · Science · doi:10.1126/science.7527157 · Cited by 247
THE ROLE OF CXC CHEMOKINES AS REGULATORS OF ANGIOGENESIS
Strieter, R. M., Polverini, P. J., Arenberg, D. A., & Kunkel, S. L. (1995) · Shock · doi:10.1097/00024382-199509000-00001 · Cited by 236
D'Angelo, G., Struman, I., Martial, J., & Weiner, R. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6374 · Cited by 227
Molecular evolution and domain structure of plasminogen‐related growth factors (HGF/SF and HGF1/MSP)
Donate, L. E., Srinivasan, N., Sowdhamini, R., Gherardi, E., Blundell, T. L., & Aparicio, S. (1994) · Protein Science · doi:10.1002/pro.5560031222 · Cited by 177
Gupta, S. K., Hassel, T., & Singh, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7799 · Cited by 141
Cao, Y., Chen, C., Weatherbee, J. A., Tsang, M., & Folkman, J. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.6.2069 · Cited by 135
Self-citationWilson, C., Goberdhan, D. C. I., & Steller, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7109 · Cited by 123
Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth.
Homandberg, G. A., Williams, J. E., Grant, D., Schumacher, B. L., & Eisenstein, R. (1985) · PubMed · Cited by 115
Crystal and molecular structure of human plasminogen kringle 4 refined at 1.9-.ANG. resolution
Mulichak, A. M., Tulinsky, A., & Ravichandran, K. G. (1991) · Biochemistry · doi:10.1021/bi00107a029 · Cited by 103
Amino acid sequence of human prothrombin fragments 1 and 2.
Walz, D. A., Hewett‐Emmett, D., & Seegers, W. H. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.5.1969 · Cited by 90
Menhart, N., Sehl, L. C., Kelley, R. F., et al. (1991) · Biochemistry · doi:10.1021/bi00221a031 · Cited by 66
Marti, D. N., Schaller, J., Ochensberger, B., et al. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb19959.x · Cited by 48
Self-citationHuman Acidic Fibroblast Growth Factor Overexpressed in Insect Cells Is Not Secreted into the Medium
Cao, Y., & Pettersson, R. F. (1990) · Growth Factors · doi:10.3109/08977199009037497 · Cited by 38
Self-citationNELSON, J., Allen, W. E., Scott, W. N., BAILIE, J. R., Walker, B., McFerran, N. V., & Wilson, D. J. (1995) · Cancer Research · Cited by 35
Functional independence of the kringle 4 and kringle 5 regions of human plasminogen
Menhart, N., McCance, S. G., Sehl, L. C., et al. (1993) · Biochemistry · doi:10.1021/bi00085a010 · Cited by 28
Self-citationSolution structure of the ɛ‐aminohexanoic acid complex of human plasminogen kringle 1
Rejante, M. R., & Llinás, M. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18809.x · Cited by 24
Self-citation
Cited by
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Self-citationThe plasminogen activation system in tumor growth, invasion, and metastasis
Andreasen, P. A., Egelund, R., & Petersen, H. H. (2000) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050497 · Cited by 943
Mechanisms of normal and tumor-derived angiogenesis
Papetti, M., & Herman, I. M. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00389.2001 · Cited by 809
Angiogenesis: regulators and clinical applications
Liekens, S., De Clercq, E., & Neyts, J. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00529-3 · Cited by 748
Combined effects of angiostatin and ionizing radiation in antitumour therapy
Mauceri, H. J., Hanna, N. N., Beckett, M. A., Gorski, D. H., Staba, M.-J., Stellato, K. A., Bigelow, K., Heimann, R., Gately, S., Dhanabal, M., et al. (1998) · Nature · doi:10.1038/28412 · Cited by 668
Metadata
- Authors
- Cao, Y., Ji, R. W., Davidson, D., Schaller, J., Marti, D., Söhndel, S., McCance, S. G., O'Reilly, M. S., Llinás, M., & Folkman, J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1996-11
- Volume
- 271
- Issue
- 46
- Pages
- 29461-29467
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2036443538
- Cited by
- 368
- References
- 42
- FWCI
- 5.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.